Modified Capecitabine and Oxaliplatin (mCAPOX) for Patients With GI Malignancies

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Modified Capecitabine and Oxaliplatin (mCAPOX) for Patients With GI Malignancies	GI Cancers	Enrolling by invitation	Phase 2	2026-02-05		NCT06648785

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Vermont Medical Center	23

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Vermont	Burlington	United States	26
University of Vermont Medical Center	Burlington	United States	157

Clinical trials